Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)
Clinical trial NCT06393504 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06393504
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-30
- Primary completion
- 2028-04-01
- Enrollment
- 2095
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.